Formulation development and optimization: Encapsulated system of atenolol and Glyburide

Journal Title: Pakistan Journal of Pharmaceutical Sciences - Year 2016, Vol 29, Issue 2

Abstract

 Purpose: Objective of this study is to develop; tablet- in- a capsule system, to deliver Atenolol 25mg and Glyburide 5mg in the hard gelatin capsule. In order to improve patient compliance and reduce problems associated with complex therapeutic regimen Atenolol (cardio-selective beta-blocker) and Glyburide (anti-diabetic; sulfonylurea) are commonly, prescribed to the diabetic hypertensive patient. Metgod: In present work six different formulations of Atenolol (AF1-AF6) and Glyburide (GF1-GF6) were prepared by direct compression method using Avicel, Lactose DC, Crospovidone and Magnesium Stearate in different proportions and encapsulated in hard gelatin shells. Post compression parameters i.e. weight variation, diameter variation, thickness variation, hardness variation, % friability, disintegration, % drug release were determined at different pH 1.2, 4.5 and 6.8, and subjected to dissolution profile comparison through similarity factor (f2). Results: Stability studies were performed and shelf lives were calculated by R-Gui Stab R console 2.15.2 and determined to be 15and 27 months for Atenolol and Glyburide respectively. The percentage drug contents of Atenolol and Glyburide were estimated spectrophotometerically at 286nm and 314.7nm respectively. Formulations CF1-CF6 (encapsulated) were subjected to weight variation, disintegration and dissolution tests and subjected to model dependant analysis for dissolution studies. The simultaneous quantitation of Atenolol and Glyburide for content assay was done by HPLC method of analysis. Conclusion: formulation CF6 is showing highest coefficient of correlation values for all models applied. So we can conclude that the proposed system can improve patient compliance by increasing the ease of administration of two drugs together.

Authors and Affiliations

Madiha Maboos , Rabia Ismail Yousuf , Muhammad Harris Shoaib

Keywords

Related Articles

 Histopathologic changes in liver and kidney of male sprague dawley rats treated with extract of Cardiospermum halicacabum L.

 In traditional medicine Cardiospermum halicacabum L. (Sapindeaceae) is used against various ailments such as rheumatism, nervous diseases, stiffness of the limbs and snakebite. Leaves are crushed and made into a te...

 Inhibitory effect of Aristolochia fruit on Cytochrome P450 isozymes in vitro and in vivo

 The mature fruits of Aristolochia debilis, known in China by the name, “Madouling” has been popularly prescribed in Asia, particularly in China, to treat a range of conditions including gynaecological problems, art...

 Evaluation of medicinal value of Epimedium elatum on the basis of pharmacologically active constituents, Icariin and Icariside-II

 Epimedium L. is well known medicinal genus of Chinese pharmacopoeia. Various species are ethno-botanically used against diseases of eye and kidney, impotence, asthma, arthritis and hypertension; besides being used...

 Plant diversity and conservation status of Himalayan Region Poonch Valley Azad Kashmir (Pakistan)

 The plant diversity of Himalayan region has been reduced to greater extent due to environmental degradation and human exploitation. Anthropogenic disturbance was the major factor responsible for fragmentation of fo...

 Study of klotho gene transfer for the protective effect of the coronary of diabetic rats

 The authors model diabetes in rats, and inject the rats with Klotho gene. Then the levels of serum lipoprotein are tested, measuring the thickness of coronary artery intima and the ratio of intima and media to see...

Download PDF file
  • EP ID EP96109
  • DOI -
  • Views 91
  • Downloads 0

How To Cite

Madiha Maboos, Rabia Ismail Yousuf, Muhammad Harris Shoaib (2016).  Formulation development and optimization: Encapsulated system of atenolol and Glyburide. Pakistan Journal of Pharmaceutical Sciences, 29(2), 569-577. https://europub.co.uk./articles/-A-96109